Development of KB004, a Therapeutic Antibody Targeting EphA3 in Solid and Hematopoietic Cancers

Description

Tea will be served at 1:45 pm.

Audience

This program is for the research community.

Date & Time(s)

Location

Memorial Sloan Kettering Cancer Center
Rockefeller Research Laboratories
430 East 67th Street
Room RRL-116
New York, NY 10065

Sponsor(s)

Structural Biology Program

Speaker(s)

Martin Lackmann, PhD
Associate Professor
Department of Biochemistry & Molecular Biology
Monash University
Victoria, Australia